Literature DB >> 25476142

Association of an Exon SNP of SLC2A9 Gene with Hyperuricemia Complicated with Type 2 Diabetes Mellitus in the Chinese Male Han Population.

Shi-Chao Xing1,2, Xu-Fu Wang3, Zhi-Min Miao3, Xue-Zhi Zhang3, Jun Zheng4, Ying Yuan5.   

Abstract

Several recent genome-wide association studies and following studies have identified that genetic variants of SLC2A9 are associated with hyperuricemia (HUA) and diabetes mellitus (DM). Here, we set to investigate whether the exon 9 of SLC2A9 gene variations is associated with HUA complicated with Type 2 DM (T2DM) in the Chinese male Han population. The present study was designed to study rs2280205 polymorphism in exon 9 of SLC2A9 in 232 Chinese male subjects. Rs2280205 locus was genotyped in 52 T2DM subjects, 65 HUA subjects, 55 subjects with HUA complicated with T2DM, as well as 60 control subjects in this study. DNA from peripheral blood was purified and amplified by polymerase chain reaction (PCR). The PCR products were then digested by restriction enzyme MSPI, and part of PCR products was sequenced and analyzed. There was no significant difference in the levels of cholesterol, creatinine, and urea nitrogen between the Control Group and the HUA group. There was also no significant difference in levels of cholesterol between the DM group and Control Group. No significant difference in cholesterol and uric acid was observed between the HUA group and the HUA accompanied with DM group (P > 0.05). However, there was no statistical significance in the genotype frequency in these groups (P > 0.01). Results of the present study suggest that the exon 9 of SLC2A9 gene 109C/T polymorphism is not associated with HUA and diabetes in population living in the coastal area of Shandong province, China.

Entities:  

Keywords:  Diabetes mellitus; Gout; Hyperuricemia; SLC2A9; Single-nucleotide polymorphism

Mesh:

Substances:

Year:  2015        PMID: 25476142     DOI: 10.1007/s12013-014-0353-2

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  3 in total

1.  Amplicon targeted resequencing for SLC2A9 and SLC22A12 identified novel mutations in hypouricemia subjects.

Authors:  Zhaowei Zhou; Ke Wang; Juan Zhou; Can Wang; Xinde Li; Lingling Cui; Lin Han; Zhen Liu; Wei Ren; Xuefeng Wang; Keke Zhang; Zhiqiang Li; Dun Pan; Changgui Li; Yongyong Shi
Journal:  Mol Genet Genomic Med       Date:  2019-05-26       Impact factor: 2.183

2.  Genome-wide association analysis identifies multiple loci associated with kidney disease-related traits in Korean populations.

Authors:  Jeonghwan Lee; Young Lee; Boram Park; Sungho Won; Jin Suk Han; Nam Ju Heo
Journal:  PLoS One       Date:  2018-03-20       Impact factor: 3.240

3.  An Intron Variant of SLC2A9 Increases the Risk for Type 2 Diabetes Mellitus Complicated with Hyperuricemia in Chinese Male Population.

Authors:  Xuan-Long Yi; Jiang Li; Dong-Mei Meng; Yan-Jun Liu; Yan-Hong Liu; Hong-Min Ma; Ying Yuan; Shi-Chao Xing
Journal:  Iran J Public Health       Date:  2018-06       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.